1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 17 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progressionPaterson, E.; Kazenwadel, J.; Bert, A.; Khew-Goodall, Y.; Ruszkiewicz, A.; Goodall, G.
2013Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening ProgramCole, S.; Tucker, G.; Osborne, J.; Byrne, S.; Bampton, P.; Fraser, R.; Young, G.
2013Risks of colorectal and other cancers after endometrial cancer for women with lynch syndromeWin, A.; Lindor, N.; Winship, I.; Tucker, K.; Buchanan, D.; Young, J.; Rosty, C.; Leggett, B.; Giles, G.; Goldblatt, J.; Macrae, F.; Parry, S.; Kalady, M.; Baron, J.; Ahnen, D.; Marchand, L.; Gallinger, S.; Haile, R.; Newcomb, P.; Hopper, J.; et al.
2013Germline mutations in the polyposis-associated genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 are not common in individuals with Serrated Polyposis SyndromeClendenning, M.; Young, J.; Walsh, M.; Woodall, S.; Arnold, J.; Jenkins, M.; Win, A.; Hopper, J.; Sweet, K.; Gallinger, S.; Rosty, C.; Parry, S.; Buchanan, D.; Toland, A.
2013Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancerWalters, R.; Williamson, E.; English, D.; Young, J.; Rosty, C.; Clendenning, M.; Walsh, M.; Parry, S.; Ahnen, D.; Baron, J.; Win, A.; Giles, G.; Hopper, J.; Jenkins, M.; Buchanan, D.
2013Germline variants and advanced colorectal adenomas: Adenoma prevention with celecoxib trial genome-wide association studyWang, J.; Carvajal-Carmona, L.; Chu, J.; Zauber, A.; Kubo, M.; Matsuda, K.; Dunlop, M.; Houlston, R.; Sieber, O.; Lipton, L.; Gibbs, P.; Martin, N.; Montgomery, G.; Young, J.; Baird, P.; Ratain, M.; Nakamura, Y.; Weiss, S.; Tomlinson, I.; Bertagnolli, M.
2013PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survivalRosty, C.; Young, J.; Walsh, M.; Clendenning, M.; Sanderson, K.; Walters, R.; Parry, S.; Jenkins, M.; Win, A.; Southey, M.; Hopper, J.; Giles, G.; Williamson, E.; English, D.; Buchanan, D.; Ashktorab, H.
2013Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer casesBuchanan, D.; Win, A.; Walsh, M.; Walters, R.; Clendenning, M.; Nagler, B.; Pearson, S.; Macrae, F.; Parry, S.; Arnold, J.; Winship, I.; Giles, G.; Lindor, N.; Potter, J.; Hopper, J.; Rosty, C.; Young, J.; Jenkins, M.
2013PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancerDay, F.; Jorissen, R.; Lipton, L.; Mouradov, D.; Sakthianandeswaren, A.; Christie, M.; Li, S.; Tsui, C.; Tie, J.; Desai, J.; Xu, Z.; Molloy, P.; Whitehall, V.; Leggett, B.; Jones, I.; McLaughlin, S.; Ward, R.; Hawkins, N.; Ruszkiewicz, A.; Moore, J.; et al.
2013Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC clinical trials group and AGITG co.Siu, L.; Shapiro, J.; Jonker, D.; Karapetis, C.; Zalcberg, J.; Simes, J.; Couture, F.; Moore, M.; Price, T.; Siddiqui, J.; Nott, L.; Charpentier, D.; Liauw, W.; Sawyer, M.; Jefford, M.; Magoski, N.; Haydon, A.; Walters, I.; Ringash, J.; Tu, D.; et al.

Discover